2m 2m 2m 2m 2m 2m 2m
KYMERA THERAP (KYMR)
NASDAQ
$107.37-$2.75 (-2.50%)
Price as of Oct 02, 2026 5:07 PM EDT- $9.2BMarket Cap
- 96.64%1-Year Change
- BiotechnologyIndustry
KYMERA THERAP (KYMR)
$107.37-$2.75 (-2.50%)
KYMR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $110.12 | ||
Change | -$1.67 (-1.49%) | ||
Open | $111.79 | ||
High | $116.20 | ||
Low | $109.41 | ||
Previous Close | $111.79 | ||
Volume | 1,051,066 | ||
30-Day Average Volume | 769,806 | ||
1-Week Change | -4.91% | ||
1-Month Change | -7.50% | ||
1-Year Change | 96.64% | ||
3-Year Change | 692.23% | ||
5-Year Change | 82.86% | ||
Fundamentals | |||
Shares Outstanding | 83.2M | ||
Total Assets | $1.6B | ||
Market Cap | $9.2B | ||
Enterprise Value | $9.0B | ||
Period: QTR TTM FY | |||
Revenue | $65.0M | ||
Net Income | -$61.2M | ||
Free Cash Flow | -$54.5M | ||
EBIT | -$61.1M | ||
EBITDA | -$59.1M | ||
Net Working Capital | $665.9M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -153 | ||
Enterprise Value/Revenue | 139 | ||
P/B | 6 | ||
P/E | -178 | ||
PEG | -14 | ||
Price/Free Cash Flow | -168 | ||
Price/Operating Cash Flow | -169 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue